Call for Abstracts

All participants are invited to submit abstracts
for presentation at MipTec 2009

Deadlines for abstract submission: Short Oral Communication - April 6, 2009 Poster - July 15, 2009 Poster deadline extended to July 28

Abstracts may only be submitted via Internet.

In order to standardize the abstract layout we ask you to read the preparation guidelines at this link CAREFULLY!

 

GUIDELINES for submission of abstracts:

1. Abstracts may be submitted only via Internet. Please make sure to state your correct E-mail address as well as your full name and company (for publishing purposes).
2. Abstracts submitted via fax or E-mail will not be accepted.
3. All abstracts must be submitted and presented in English.
4. Abstracts should contain original material neither published nor presented elsewhere prior to October 13, 2009.
5. The abstract text may not be longer than 2500 characters, including spaces, excluding title and authors.
6. Tables, charts and other graphics may be included in the abstract in gif or jpg format of high resolution and suitable for reproduction in black & white. A separate upload button is provided (max. 3 graphics per abstract of not more than 20kb in total).
7. Avoid complex mathematical formulae. For the symbols ≤ or ≥, type instead <= or >= and for e.g. 10⁶, type instead 10^6. Avoid Greek letters and symbols. Instead of ‘IFN-γ’ use for example ‘IFN-g’ or ‘IFN-gamma’, etc.
8. All abbreviations must be defined the first time they appear in your text (but, do not define in the title).
9. Authors are requested to select a topic under which they wish their abstract to be reviewed.
10. Select your preferred method of presentation: Oral or poster.
    As the number of oral time slots is limited, the Program Committee may ask authors who prefer oral, to present their work as a poster.
    Abstracts submitted after the oral deadline April 6, 2009 will be automatically considered for poster presentation!
11. After having submitted your abstract, you will receive a confirmation by E-mail with the following information:
    
    • reference number of your abstract (for correspondence and questions that may arise)
    • your personal user code (E-mail address) and password.
    Should you wish to make corrections to an abstract already submitted or if you wish to submit other abstracts later, you may use your personal user code and password. Please note that alterations cannot be made after the above mentioned abstract deadlines.
    If you do not receive a confirmation by E-mail please contact the Abstract Hotline.
12.  Authors of Short Oral Communications will be notified of the acceptance by the end of May 2009 via E-Mail. Authors of Posters will be notified of the acceptance by beginning of August 2009.
13. Acceptance of a paper implies registration and attendence at the conference.
    

 

If you have difficulties in submitting your abstract or if you need any further information, please contact the Abstract Hotline.
Phone: +41 61 686 77 22 (Monday - Friday during CET business hours)
E-mail: abstracts.ch@congrex.com

 

Topics for Abstract Submission:

1. Drug Discovery Technologies
   Main Oral sessions in this topic will focus  on new technologies as well as on improvements of existing technologies. These are having, or may have, significant impact on how we identify innovative compounds and develop them into lead candidates for new therapies.
2. Biological Space: Targets and Tools
   Main Oral sessions in this topic will focus on biological aspects, new strategies for drug discovery in disease areas of the developing world and the biology of sense receptors.
3. Chemical Space: Maximizing Compound Value
   Main Oral sessions in this topic will focus on chemical diversity and chemical space, scaffold hopping and similarity and bioisosteres and new uses for existing drugs
4. Early Safety Evaluation
   Main Oral sessions in this topic will focus on predicting, measuring and improving ADME properties, modelling pharmacokinetics endpoints and the role of toxicology in the early stages of drug discovery
5. Pharmacodynamics / Biomarkers
   Main Oral sessions in this topic will focus on new developments and case studies in biomarker development, diagnostic tool applications and pharmacodynamic studies.
6. Structural and Computational Drug Discovery
   Main Oral sessions in this topic will focus on advances in kinase inhibitor design, virtual screening applications and structure-based design of protein therapeutics
7. Biopharmaceuticals
   Main Oral sessions in this topic will focus on therapeutic antibodies and beyond as well as biopharmaceuticals (excluding antibodies)

Notification of Authors
Abstracts are subject to approval by the Program Committee and to final assignment for inclusion in the program as an oral or poster presentation. Authors will be notified by E-mail (therefore it is essential that you indicate your correct E-mail address). Authors will be informed as to whether they are to present their abstract orally or in the form of a poster. Full instructions concerning the preparation and presentation will be included.

 

Publication
All accepted abstracts will be published and handed out to the participants onsite with the conference documentation.

 

Young Scientists Travel Grant
Young scientists interested in this travel grant should click the appropriate checkbox during the online abstract submission process. You will be required to upload a copy of your student identification as proof of eligibility. Prepare this document in one of the following formats: MS Word document, gif, jpg or pdf file.
If you have difficulties uploading your passport copy, please contact the Abstract Hotline on
++41 61 686 7722

 

Applications without valid student identification or arriving after April 6, 2009 (Oral)/July 15, 2009 (Poster) will not be considered.

Online application only

 

 

Abstract submission has been closed.